DE3782468T2 - Verfahren zur behandlung von maennlicher sexueller dysfunktion. - Google Patents

Verfahren zur behandlung von maennlicher sexueller dysfunktion.

Info

Publication number
DE3782468T2
DE3782468T2 DE8787306224T DE3782468T DE3782468T2 DE 3782468 T2 DE3782468 T2 DE 3782468T2 DE 8787306224 T DE8787306224 T DE 8787306224T DE 3782468 T DE3782468 T DE 3782468T DE 3782468 T2 DE3782468 T2 DE 3782468T2
Authority
DE
Germany
Prior art keywords
sexual dysfunction
male sexual
treating male
dhc
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787306224T
Other languages
English (en)
Other versions
DE3782468D1 (de
Inventor
Wesley R Anderson
Nicholas S Bodor
James W Simpkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Application granted granted Critical
Publication of DE3782468D1 publication Critical patent/DE3782468D1/de
Publication of DE3782468T2 publication Critical patent/DE3782468T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/559—Redox delivery systems, e.g. dihydropyridine pyridinium salt redox systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
DE8787306224T 1986-08-04 1987-07-14 Verfahren zur behandlung von maennlicher sexueller dysfunktion. Expired - Lifetime DE3782468T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/892,861 US4863911A (en) 1986-08-04 1986-08-04 Method for treating male sexual dysfunction

Publications (2)

Publication Number Publication Date
DE3782468D1 DE3782468D1 (de) 1992-12-10
DE3782468T2 true DE3782468T2 (de) 1993-03-18

Family

ID=25400626

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787306224T Expired - Lifetime DE3782468T2 (de) 1986-08-04 1987-07-14 Verfahren zur behandlung von maennlicher sexueller dysfunktion.

Country Status (8)

Country Link
US (1) US4863911A (de)
EP (1) EP0256668B1 (de)
JP (1) JP2646568B2 (de)
AT (1) ATE81977T1 (de)
AU (1) AU603368B2 (de)
CA (1) CA1300020C (de)
DE (1) DE3782468T2 (de)
IE (1) IE61350B1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5925774A (en) * 1991-01-07 1999-07-20 Pherin Corporation Estrenes for inducing hypothalamic effects
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
DE4319096C1 (de) * 1993-06-08 1994-09-08 Kuhl Herbert Prof Dr Phil Nat Hormonales Mittel zur Vorbeugung und Behandlung arterieller Erkrankungen beim Mann
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
ES2091724B1 (es) * 1995-04-07 1997-06-01 Ropero Wermenlinger Luis Nueva locion potenciadora de la capacidad sexual en el hombre, procedimiento para su preparacion y sus aplicaciones.
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
US20030004170A1 (en) * 1997-05-19 2003-01-02 Zonagen, Inc. Combination therapy for modulating the human sexual response
US6482426B1 (en) 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
BRPI0003386B8 (pt) * 2000-08-08 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda pró-droga homo ou heterodiméricas úteis no tratamento de doenças ou disfunções mediadas por fosfodiesterases; composições farmacêuticas contendo a pró-droga ou seus sais farmacêuticos aceitáveis; processo de obtenção destas pró-drogas
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US6803060B2 (en) 2000-09-07 2004-10-12 Joe Reyes Composition to boost libido
WO2005011617A2 (en) * 2003-07-31 2005-02-10 Ivax Corporation Transmucosal dosage forms for brain-targeted steroid chemical delivery systems
AU2006299833B2 (en) 2005-10-12 2012-04-12 Besins Healthcare Luxembourg Sarl Improved testosterone gel and method of use
US20100087407A1 (en) * 2006-08-04 2010-04-08 James Symons use of aromatase inhibitors
US20100292150A1 (en) * 2007-12-10 2010-11-18 Meditrina Pharmaceuticals, Inc. Treatment of Menorrhagia with Aromatase Inhibitor
CN102114024B (zh) * 2009-12-30 2012-05-30 宋杰 预防月经期偏头痛的复方雌谷胶囊

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035507A (en) * 1975-04-17 1977-07-12 Interx Research Corporation Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease
NL7506407A (nl) * 1975-05-30 1976-12-02 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.
US4210644A (en) * 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US4540564A (en) * 1982-05-18 1985-09-10 University Of Florida Brain-specific drug delivery
EP0221588A3 (de) * 1982-05-18 1988-09-21 University Of Florida Gehirnspezifische Arzneimittelabgabe
US4479932A (en) * 1982-05-18 1984-10-30 University Of Florida Brain-specific drug delivery
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US4617298A (en) * 1985-10-22 1986-10-14 University Of Florida Method and compositions for weight control

Also Published As

Publication number Publication date
AU603368B2 (en) 1990-11-15
IE61350B1 (en) 1994-11-02
EP0256668A2 (de) 1988-02-24
CA1300020C (en) 1992-05-05
AU7630887A (en) 1988-02-11
ATE81977T1 (de) 1992-11-15
JPS6399095A (ja) 1988-04-30
JP2646568B2 (ja) 1997-08-27
US4863911A (en) 1989-09-05
IE871749L (en) 1988-02-04
DE3782468D1 (de) 1992-12-10
EP0256668B1 (de) 1992-11-04
EP0256668A3 (en) 1989-10-04

Similar Documents

Publication Publication Date Title
DE3782468T2 (de) Verfahren zur behandlung von maennlicher sexueller dysfunktion.
AU2003283282A8 (en) Tubulysins, method for producing the same and tubulysin preparations
GEP20012530B (en) Neuroactive Steroids of the Androstane and Pregnane Series
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
HK186396A (en) Benzo(5,6)cyclo-heptapyridines compositions and method of use
ATE195740T1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
IL133434A (en) Use of polyamine polymers in the preparation of medicaments for removing bile salts and for treating hypercholesterolemia
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
IL98258A0 (en) Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046
HU905682D0 (en) Early ejaculation treatment by using sertraline
EP1304329A3 (de) Pyridonkarbonsaüre Derivate und deren Verwendung als antibakterielle Wirkstoffe
FI904035A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia 4-substituoituja 17 -(syklopropyyliamino)androst-5-eenijohdannaisia, jotka ovat hyödyllisiä C17-20-lyaasi-inhibiittoreina
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
EP0197488A3 (de) 1,4-Dihydropyridinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel und ihre Verwendung
EP0220844A3 (de) Verwendung von Östrogen-dihydropyridinverbindungen zur Gewichtsreglung
BG101220A (en) N-substituted 3-azabicyclo (93.2.0) heptane derivatives,their preparation and use
ES2006619A6 (es) Un metodo para preparar derivados de piridil-y pirimidil-piperazinas.
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
ATE71099T1 (de) Calcium-4,6-dioxo-4h-pyrano(3,2-g>-chinolin-2,8 dicarboxylat-derivat, verfahren zu seiner herstellung und dieses enthaltende zusammensetzungen.
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
EP0354568A3 (de) Catechol-Derivate
IT9086204A0 (it) Metodo per la cura dell'impotenza erettiva maschile
IL93599A0 (en) Kit and/or composition for the prevention or treatment of aids
IL96501A0 (en) 14alpha,17alpha-estratrienes,processes for the preparation thereof and pharmaceutical compositions containing the same
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition